Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Cancervax
AddedFeb 18, 2024
UpdatedJun 18, 2026
Cancervax

Cancervax

Seed

CancerVAX Biotech: Santa Barbara-based medical firm innovating universal cancer treatments.

HQ
Santa Barbara, CA, US
Founded
2021
Overview
Compare
Fundraising
Employees
News
Website

Founded in Santa Barbara, California, CancerVAX Biotech is a pioneering biotechnology company with a core mission to develop universal cancer treatments by leveraging the body’s immune system. The company focuses on creating innovative therapies that aim to provide effective and accessible cancer treatment options. Their market focus includes patients suffering from various types of cancer, with the goal of revolutionizing cancer care and improving patient outcomes globally.

Notable affiliated individuals and investors include leading experts in oncology and immunotherapy, though specific names are not provided. Key achievements for CancerVAX Biotech include significant advancements in immunotherapy research and development. The company's impact is marked by its potential to transform cancer treatment paradigms, offering hope for more effective and less invasive treatment options.

Cancervax - Similar Companies

Curevax logo

Curevax

INmune Bio logo

INmune Bio

inmunebio.com

Iovance Biotherapeutics logo

Iovance Biotherapeutics

iovance.com

EpiVax Oncology logo

EpiVax Oncology

epivaxtx.com

Immune-Onc Therapeutics logo

Immune-Onc Therapeutics

immuneonc.com

Agilvax logo

Agilvax

Ubivac logo

Ubivac

ubivac.com

SunnyBay BioTech logo

SunnyBay BioTech

Imvax logo

Imvax

imvax.com

Adventris Pharmaceuticals logo

Adventris Pharmaceuticals

Imvaq Therapeutics logo

Imvaq Therapeutics

Irazu Oncology logo

Irazu Oncology

irazuoncology.com

MaveriX Oncology logo

MaveriX Oncology

Umoja Biopharma logo

Umoja Biopharma

Tvax Biomedical logo

Tvax Biomedical

Cancervax - Quick Facts

Who are Cancervax's competitors?

Companies similar to Cancervax include Curevax, INmune Bio, Iovance Biotherapeutics and EpiVax Oncology.

When was Cancervax founded?

Cancervax was founded in 2021.

Where is Cancervax's headquarters located?

Cancervax's headquarters is located in Santa Barbara, CA, US.

When was Cancervax's last funding round?

Cancervax's most recent funding round was for $500k (USD) in October 2023.

How much has Cancervax raised to-date?

As of Oct 26, 2023, Cancervax has raised a total of $500k (USD).

How many employees does Cancervax have?

Cancervax has 13 employees as of Feb 4, 2024.

Cancervax - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Customer
  • Enterprise
  • Government
Main Product
  • Cancer Treatment
Tags
  • Consulting
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified